Edition:
United Kingdom

Nipro Corp (8086.T)

8086.T on Tokyo Stock Exchange

1,259JPY
24 May 2019
Change (% chg)

¥20 (+1.61%)
Prev Close
¥1,239
Open
¥1,233
Day's High
¥1,261
Day's Low
¥1,230
Volume
643,800
Avg. Vol
708,223
52-wk High
¥1,594
52-wk Low
¥1,214

Latest Key Developments (Source: Significant Developments)

R&I affirms Nipro's rating at "BBB+" and says stable outlook -R&I
Thursday, 20 Sep 2018 

Sept 20(Reuters) - Nipro Corp <8086.T>:Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "BBB+" -R&I.Rating outlook stable -R&I.  Full Article

R&I affirms Nipro's rating at "BBB+" and says stable outlook -R&I
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Nipro Corp <8086.T> ::Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "BBB+" -R&I.Says rating outlook stable -R&I.  Full Article

Lilly gets civil investigative demand from Minnesota AG for insulin product pricing‍​
Friday, 28 Jul 2017 

July 28 (Reuters) - Eli Lilly And Co ::Says got civil investigative demand from Minnesota's office of Attorney General relating to pricing, sale of insulin products - SEC filing‍​.Says offices of attorneys general in California and Florida have requested information relating to pricing of company's insulin products.Says lost patent exclusivity for Strattera in the U.S. in May 2017, and generic versions of Strattera were approved in the same month.Entry of generic versions of Strattera has caused "rapid and severe" decline in revenue, which will have material adverse effect on results.In May, Japanese Patent Office resumed 1 of 2 remaining demands for invalidation of company's two vitamin regimen patents, brought by Nipro Corp.  Full Article